Insider · CIK 0001492710

Freitag Gregory Gene

Reports to the SEC for 4 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001492710

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-12	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+54.9K sh	—	—	54,876
2025-07-11	ZVSAZyVersa Therapeutics, Inc. · Stock OptionsA Award	Director	AAward	+11.1K sh	—	—	11,066
2025-06-11	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+22.7K sh	—	—	22,700
2025-02-28	PDSBPDS Biotechnology Corp · Common WarrantP Purchase	Director	PPurchase	+15.1K sh	—	—	15,060
2025-02-28	PDSBPDS Biotechnology CorpP Purchase	Director	PPurchase	+15.1K sh	$1.66	+$25K	61,213
2024-06-24	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2024-06-04	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	0
2024-06-04	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	—	—	283,498
2024-03-07	AXGNAxogen, Inc.S Sale	Director	SSale	−25K sh	$9.00	−$225K	271,594
2023-09-01	AXGNAxogen, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+20.4K sh	—	—	20,436
2023-09-01	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+11.9K sh	—	—	11,904
2023-07-14	PDSBPDS Biotechnology Corp · Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2023-06-01	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,459 sh	—	—	296,594
2023-06-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,459 sh	—	—	0
2023-06-01	AXGNAxogen, Inc.S Sale	Director	SSale	−29.5K sh	$8.74	−$258K	290,135
2023-06-01	AXGNAxogen, Inc.S Sale	Director	SSale	−12.5K sh	$8.65	−$108K	319,615
2023-05-24	ZVSAZyVersa Therapeutics, Inc. · Stock OptionsA Award	Director	AAward	+132 sh	—	—	132
2023-05-23	AXGNAxogen, Inc.S Sale	Director	SSale	−4,640 sh	$9.26	−$43K	332,115
2023-05-23	AXGNAxogen, Inc.S Sale	Director	SSale	−2,828 sh	$9.17	−$25.9K	336,755
2022-11-14	AXGNAxogen, Inc.S Sale	Director	SSale	−13K sh	$12.74	−$166K	339,583
2022-11-08	AXGNAxogen, Inc.S Sale	Director	SSale	−13K sh	$12.50	−$163K	352,583
2022-08-10	AXGNAxogen, Inc.S Sale	Director	SSale	−8,886 sh	$9.70	−$86.2K	365,583
2022-08-08	AXGNAxogen, Inc.S Sale	Director	SSale	−13K sh	$10.37	−$135K	374,469
2022-08-04	AXGNAxogen, Inc.S Sale	Director	SSale	−24K sh	$10.64	−$255K	387,515
2022-07-25	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−83K sh	—	—	0
2022-07-25	AXGNAxogen, Inc.F Tax Payment	Director	FTax Payment	−30.3K sh	$9.26	−$281K	411,515
2022-07-25	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+83K sh	$3.38	+$281K	441,811
2022-06-28	PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2022-06-01	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,036 sh	—	—	358,811
2022-06-01	AXGNAxogen, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,036 sh	—	—	0
2022-06-01	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)A Award	Director	AAward	+11.8K sh	—	—	11,811
2022-06-01	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+6,459 sh	—	—	6,459
2021-06-17	PDSBPDS Biotechnology Corp · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2021-06-17	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−9,250 sh	—	—	0
2021-06-17	AXGNAxogen, Inc.F Tax Payment	Director	FTax Payment	−8,781 sh	$20.92	−$184K	355,775
2021-06-17	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,250 sh	$19.17	+$177K	364,556
2021-06-15	PDSBPDS Biotechnology CorpP Purchase	Director	PPurchase	+5,882 sh	$8.50	+$50K	46,153
2021-06-04	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24K sh	$3.67	+$88.1K	355,306
2021-06-04	AXGNAxogen, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−24K sh	$3.67	−$88.1K	0
2021-06-01	AXGNAxogen, Inc. · Stock Option (right to purchase)A Award	Director	AAward	+6,030 sh	—	—	6,030
2021-06-01	AXGNAxogen, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,036 sh	—	—	3,036
2021-05-26	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$8.95	+$447K	331,306
2021-05-26	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$5.45	+$32.7K	266,306
2021-05-26	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−23K sh	$3.67	−$84.2K	0
2021-05-26	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	$5.09	−$45.8K	0
2021-05-26	AXGNAxogen, Inc. · Employee Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	$5.45	−$32.7K	0
2021-05-26	AXGNAxogen, Inc. · Stock Option (right to purchase)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	$5.45	−$81.8K	0
2021-05-26	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+23K sh	$3.67	+$84.2K	251,306
2021-05-26	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,000 sh	$5.09	+$45.8K	260,306
2021-05-26	AXGNAxogen, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$5.45	+$81.8K	281,306

Recent filings

Accepted (ET)
Mar 34
Freitag Gregory Gene0001140361-26-007643
SEC(opens sec.gov)
Jul 154
Freitag Gregory Gene0001641172-25-019724
SEC(opens sec.gov)
Jun 114
Freitag Gregory Gene0001140361-25-022224
SEC(opens sec.gov)
Mar 34
Freitag Gregory Gene0001140361-25-006784
SEC(opens sec.gov)
Jul 184
Freitag Gregory Gene0001493152-24-028399
SEC(opens sec.gov)
Jun 254
Freitag Gregory Gene0001140361-24-031294
SEC(opens sec.gov)
Jun 64
Freitag Gregory Gene0000805928-24-000075
SEC(opens sec.gov)
Mar 84
Freitag Gregory Gene0000805928-24-000039
SEC(opens sec.gov)
Sep 74
Freitag Gregory Gene0000805928-23-000112
SEC(opens sec.gov)
Jul 174
Freitag Gregory Gene0001140361-23-034839
SEC(opens sec.gov)
Jun 54
Freitag Gregory Gene0000805928-23-000062
SEC(opens sec.gov)
May 244
Freitag Gregory Gene0000805928-23-000056
SEC(opens sec.gov)
Nov 164
Freitag Gregory Gene0000805928-22-000121
SEC(opens sec.gov)

Companies

Address

C/O PDS BIOTECHNOLOGY CORPORATION 303A COLLEGE ROAD EAST

PRINCETON, NJ, 08540